av/neumora-therapeutics--big.svg

COM:NEUMORATX

Neumora Therapeutics, Inc.

  • Stock

USD

Last Close

9.69

22/11 21:00

Market Cap

1.72B

Beta: -

Volume Today

490.17K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
cash per share
1.26
-
2.69
113.18%
2.45
9.13%
company equity multiplier
-2.10
-
-1.32
37.06%
-0.95
27.74%
1.06
210.90%
days of inventory outstanding
days of payables outstanding
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit
1.04
-
1.00
3.79%
0.96
3.65%
effective tax rate
0.03
-
enterprise value multiple
-23.89
-
-8.71
63.55%
-16.53
89.87%
fixed asset turnover
free cash flow per share
-0.18
-
-0.50
171.69%
-0.76
51.38%
gross profit margin
interest coverage
inventory turnover
long term debt to capitalization
-0.01
-
-0.00
77.67%
-0.01
273.73%
0.00
134.27%
net income per ebt
1
-
1
0%
1
0%
net profit margin
operating cash flow per share
-0.18
-
-0.50
181.84%
-0.76
52.34%
operating profit margin
payables turnover
pretax profit margin
price fair value
-26.16
-
-7.59
70.98%
-5.53
27.22%
receivables turnover
return on assets
-0.50
-
-0.55
10.23%
-0.31
44.44%
return on capital employed
-0.51
-
-0.58
15.40%
-0.34
42.25%
return on equity
1.05
-
0.73
30.62%
0.29
59.85%
total debt to capitalization
-0.02
-
-0.01
71.33%
-0.02
203.26%
0.01
157.27%

All numbers in USD (except ratios and percentages)